1 | second | 21,202 |
2 | waveone | 30 |
3 | leboyer | 24 |
4 | clinically-indicated | 18 |
5 | 60-d | 14 |
6 | 15-mg/kg | 13 |
7 | nonexercised | 13 |
8 | chisel | 11 |
9 | nike | 11 |
10 | post-protocol | 11 |
11 | piama | 10 |
12 | roll-in | 10 |
13 | 35-d | 9 |
14 | fixed-ratio | 9 |
15 | high-use | 8 |
16 | dep-ado | 7 |
17 | mid-axillary | 7 |
18 | pelican | 7 |
19 | valveless | 7 |
20 | wf-optimized | 7 |
21 | 'second | 6 |
22 | 20-cm | 6 |
23 | 25-μg | 6 |
24 | catheter-over-needle | 6 |
25 | four-cell | 6 |
26 | non-coordinating | 6 |
27 | 10-member | 5 |
28 | 2-mp-general | 5 |
29 | drug-adjusted | 5 |
30 | ha/tcp | 5 |
31 | mrcog | 5 |
32 | pre-protocol | 5 |
33 | safeboosc | 5 |
34 | explora | 4 |
35 | kopparberg | 4 |
36 | microthin | 4 |
37 | mock-crime | 4 |
38 | most-polarized | 4 |
39 | msus-guided | 4 |
40 | sepal | 4 |
41 | stone-bearing | 4 |
42 | strictly-guided | 4 |
43 | year.the | 4 |
44 | 10-centimeter | 3 |
45 | 7-product | 3 |
46 | bipronuclear | 3 |
47 | center-out | 3 |
48 | cephalothin-treated | 3 |
49 | colesevelam-treated | 3 |
50 | common-garden | 3 |
51 | cterminal | 3 |
52 | hy-droxy-ethyl | 3 |
53 | non-preloaded | 3 |
54 | precatalytic | 3 |
55 | single-stone | 3 |
56 | two-vegetable | 3 |
57 | u-ha/plla | 3 |
58 | vasco | 3 |
59 | vehicle-exposed | 3 |
60 | 2nd/3rd | 2 |
61 | accf/aha/hrs | 2 |
62 | anti-blys | 2 |
63 | biceps-curl | 2 |
64 | black-line | 2 |
65 | change-detection | 2 |
66 | contemplation/action/maintenance | 2 |
67 | endergonic | 2 |
68 | endpoint-free | 2 |
69 | enneking | 2 |
70 | first-reported | 2 |
71 | four-volume | 2 |
72 | generator-produced | 2 |
73 | golfig-2 | 2 |
74 | grammian | 2 |
75 | irving-williams | 2 |
76 | kybersept | 2 |
77 | low-fat-diet | 2 |
78 | mg/cpr | 2 |
79 | missing-not-at-random | 2 |
80 | naphazoline/pheniramine | 2 |
81 | noisiest | 2 |
82 | nonblocked | 2 |
83 | nonmagical | 2 |
84 | pagan | 2 |
85 | par4-ap | 2 |
86 | para-meth-oxy | 2 |
87 | pentalyse | 2 |
88 | posteromotoric | 2 |
89 | pronucleate | 2 |
90 | randomly-allocated | 2 |
91 | relactation | 2 |
92 | retract-and-reorder | 2 |
93 | step-execution | 2 |
94 | supra-span | 2 |
95 | taste-testing | 2 |
96 | temperate-environment | 2 |
97 | thio-morpholine | 2 |
98 | toltrazuril-treated | 2 |
99 | 'fishing | 1 |
100 | 'milky | 1 |
101 | 1-t-scale | 1 |
102 | 103-d | 1 |
103 | 160:2897-2900 | 1 |
104 | 2-8-cell | 1 |
105 | 2gc×gc | 1 |
106 | 4.6-hour | 1 |
107 | 48-pack | 1 |
108 | 5,132 | 1 |
109 | 50-watt | 1 |
110 | 99-d | 1 |
111 | adipor1-specific | 1 |
112 | alkali-condition | 1 |
113 | anji | 1 |
114 | beleagured | 1 |
115 | bio-sourced | 1 |
116 | calbindin-poor | 1 |
117 | calender | 1 |
118 | common-source | 1 |
119 | common-stress-garden | 1 |
120 | d-labeling | 1 |
121 | digestibility-balance | 1 |
122 | dpt-silenced | 1 |
123 | drug’s | 1 |
124 | dual-cartridge | 1 |
125 | enuwa | 1 |
126 | fall-winter | 1 |
127 | fill-finish | 1 |
128 | five-cell | 1 |
129 | foscarnet-ganciclovir | 1 |
130 | fragments-treated | 1 |
131 | gasification-dominated | 1 |
132 | gerda | 1 |
133 | heading/flowering | 1 |
134 | hot-weather | 1 |
135 | irradiation/absorption | 1 |
136 | l2-larval | 1 |
137 | later-presented | 1 |
138 | melting-dominated | 1 |
139 | metformin+pioglitazone+sitagliptin | 1 |
140 | mid-heating | 1 |
141 | middle-later | 1 |
142 | milk-feeding | 1 |
143 | no-body | 1 |
144 | non-body | 1 |
145 | nondrainable | 1 |
146 | nontumored | 1 |
147 | not-filled | 1 |
148 | numb-taste | 1 |
149 | peri-adolescence | 1 |
150 | post-outbreak | 1 |
151 | pre-test-feedback-post-test | 1 |
152 | pre-uremic | 1 |
153 | precontemplation-contemplation | 1 |
154 | pressure-injury | 1 |
155 | pro-t-cell | 1 |
156 | promegakaryoblast | 1 |
157 | pseudoglandular | 1 |
158 | ptb/second | 1 |
159 | pyrophilous | 1 |
160 | recrudescing | 1 |
161 | repeated-choice | 1 |
162 | risk-injury-failure-loss-end | 1 |
163 | rna-pulldown | 1 |
164 | sabbatical | 1 |
165 | sap-feeding | 1 |
166 | self-cooling | 1 |
167 | smad3-specific | 1 |
168 | sn-rich | 1 |
169 | start-of-second-crack | 1 |
170 | stereoinvertive | 1 |
171 | sublinical | 1 |
172 | ten-night | 1 |
173 | third.only | 1 |
174 | transconformation | 1 |
175 | trichiasis/entropion | 1 |
176 | vibration-treated | 1 |
177 | zero-slope | 1 |
1 | 'fishing | 1 |
2 | 'milky | 1 |
3 | 'second | 6 |
4 | 1-t-scale | 1 |
5 | 10-centimeter | 3 |
6 | 10-member | 5 |
7 | 103-d | 1 |
8 | 15-mg/kg | 13 |
9 | 160:2897-2900 | 1 |
10 | 2-8-cell | 1 |
11 | 2-mp-general | 5 |
12 | 20-cm | 6 |
13 | 25-μg | 6 |
14 | 2gc×gc | 1 |
15 | 2nd/3rd | 2 |
16 | 35-d | 9 |
17 | 4.6-hour | 1 |
18 | 48-pack | 1 |
19 | 5,132 | 1 |
20 | 50-watt | 1 |
21 | 60-d | 14 |
22 | 7-product | 3 |
23 | 99-d | 1 |
24 | accf/aha/hrs | 2 |
25 | adipor1-specific | 1 |
26 | alkali-condition | 1 |
27 | anji | 1 |
28 | anti-blys | 2 |
29 | beleagured | 1 |
30 | biceps-curl | 2 |
31 | bio-sourced | 1 |
32 | bipronuclear | 3 |
33 | black-line | 2 |
34 | calbindin-poor | 1 |
35 | calender | 1 |
36 | catheter-over-needle | 6 |
37 | center-out | 3 |
38 | cephalothin-treated | 3 |
39 | change-detection | 2 |
40 | chisel | 11 |
41 | clinically-indicated | 18 |
42 | colesevelam-treated | 3 |
43 | common-garden | 3 |
44 | common-source | 1 |
45 | common-stress-garden | 1 |
46 | contemplation/action/maintenance | 2 |
47 | cterminal | 3 |
48 | d-labeling | 1 |
49 | dep-ado | 7 |
50 | digestibility-balance | 1 |
51 | dpt-silenced | 1 |
52 | drug-adjusted | 5 |
53 | drug’s | 1 |
54 | dual-cartridge | 1 |
55 | endergonic | 2 |
56 | endpoint-free | 2 |
57 | enneking | 2 |
58 | enuwa | 1 |
59 | explora | 4 |
60 | fall-winter | 1 |
61 | fill-finish | 1 |
62 | first-reported | 2 |
63 | five-cell | 1 |
64 | fixed-ratio | 9 |
65 | foscarnet-ganciclovir | 1 |
66 | four-cell | 6 |
67 | four-volume | 2 |
68 | fragments-treated | 1 |
69 | gasification-dominated | 1 |
70 | generator-produced | 2 |
71 | gerda | 1 |
72 | golfig-2 | 2 |
73 | grammian | 2 |
74 | ha/tcp | 5 |
75 | heading/flowering | 1 |
76 | high-use | 8 |
77 | hot-weather | 1 |
78 | hy-droxy-ethyl | 3 |
79 | irradiation/absorption | 1 |
80 | irving-williams | 2 |
81 | kopparberg | 4 |
82 | kybersept | 2 |
83 | l2-larval | 1 |
84 | later-presented | 1 |
85 | leboyer | 24 |
86 | low-fat-diet | 2 |
87 | melting-dominated | 1 |
88 | metformin+pioglitazone+sitagliptin | 1 |
89 | mg/cpr | 2 |
90 | microthin | 4 |
91 | mid-axillary | 7 |
92 | mid-heating | 1 |
93 | middle-later | 1 |
94 | milk-feeding | 1 |
95 | missing-not-at-random | 2 |
96 | mock-crime | 4 |
97 | most-polarized | 4 |
98 | mrcog | 5 |
99 | msus-guided | 4 |
100 | naphazoline/pheniramine | 2 |
101 | nike | 11 |
102 | no-body | 1 |
103 | noisiest | 2 |
104 | non-body | 1 |
105 | non-coordinating | 6 |
106 | non-preloaded | 3 |
107 | nonblocked | 2 |
108 | nondrainable | 1 |
109 | nonexercised | 13 |
110 | nonmagical | 2 |
111 | nontumored | 1 |
112 | not-filled | 1 |
113 | numb-taste | 1 |
114 | pagan | 2 |
115 | par4-ap | 2 |
116 | para-meth-oxy | 2 |
117 | pelican | 7 |
118 | pentalyse | 2 |
119 | peri-adolescence | 1 |
120 | piama | 10 |
121 | post-outbreak | 1 |
122 | post-protocol | 11 |
123 | posteromotoric | 2 |
124 | pre-protocol | 5 |
125 | pre-test-feedback-post-test | 1 |
126 | pre-uremic | 1 |
127 | precatalytic | 3 |
128 | precontemplation-contemplation | 1 |
129 | pressure-injury | 1 |
130 | pro-t-cell | 1 |
131 | promegakaryoblast | 1 |
132 | pronucleate | 2 |
133 | pseudoglandular | 1 |
134 | ptb/second | 1 |
135 | pyrophilous | 1 |
136 | randomly-allocated | 2 |
137 | recrudescing | 1 |
138 | relactation | 2 |
139 | repeated-choice | 1 |
140 | retract-and-reorder | 2 |
141 | risk-injury-failure-loss-end | 1 |
142 | rna-pulldown | 1 |
143 | roll-in | 10 |
144 | sabbatical | 1 |
145 | safeboosc | 5 |
146 | sap-feeding | 1 |
147 | second | 21,202 |
148 | self-cooling | 1 |
149 | sepal | 4 |
150 | single-stone | 3 |
151 | smad3-specific | 1 |
152 | sn-rich | 1 |
153 | start-of-second-crack | 1 |
154 | step-execution | 2 |
155 | stereoinvertive | 1 |
156 | stone-bearing | 4 |
157 | strictly-guided | 4 |
158 | sublinical | 1 |
159 | supra-span | 2 |
160 | taste-testing | 2 |
161 | temperate-environment | 2 |
162 | ten-night | 1 |
163 | thio-morpholine | 2 |
164 | third.only | 1 |
165 | toltrazuril-treated | 2 |
166 | transconformation | 1 |
167 | trichiasis/entropion | 1 |
168 | two-vegetable | 3 |
169 | u-ha/plla | 3 |
170 | valveless | 7 |
171 | vasco | 3 |
172 | vehicle-exposed | 3 |
173 | vibration-treated | 1 |
174 | waveone | 30 |
175 | wf-optimized | 7 |
176 | year.the | 4 |
177 | zero-slope | 1 |
1 | 160:2897-2900 | 1 |
2 | golfig-2 | 2 |
3 | 5,132 | 1 |
4 | gerda | 1 |
5 | u-ha/plla | 3 |
6 | piama | 10 |
7 | explora | 4 |
8 | enuwa | 1 |
9 | 2gc×gc | 1 |
10 | adipor1-specific | 1 |
11 | smad3-specific | 1 |
12 | pre-uremic | 1 |
13 | endergonic | 2 |
14 | posteromotoric | 2 |
15 | precatalytic | 3 |
16 | safeboosc | 5 |
17 | 60-d | 14 |
18 | 103-d | 1 |
19 | 35-d | 9 |
20 | 99-d | 1 |
21 | dpt-silenced | 1 |
22 | bio-sourced | 1 |
23 | generator-produced | 2 |
24 | non-preloaded | 3 |
25 | msus-guided | 4 |
26 | strictly-guided | 4 |
27 | nonblocked | 2 |
28 | not-filled | 1 |
29 | nontumored | 1 |
30 | beleagured | 1 |
31 | nonexercised | 13 |
32 | vehicle-exposed | 3 |
33 | clinically-indicated | 18 |
34 | randomly-allocated | 2 |
35 | toltrazuril-treated | 2 |
36 | colesevelam-treated | 3 |
37 | cephalothin-treated | 3 |
38 | vibration-treated | 1 |
39 | fragments-treated | 1 |
40 | melting-dominated | 1 |
41 | gasification-dominated | 1 |
42 | later-presented | 1 |
43 | first-reported | 2 |
44 | drug-adjusted | 5 |
45 | wf-optimized | 7 |
46 | most-polarized | 4 |
47 | risk-injury-failure-loss-end | 1 |
48 | second | 21,202 |
49 | 'second | 6 |
50 | ptb/second | 1 |
51 | 2nd/3rd | 2 |
52 | repeated-choice | 1 |
53 | digestibility-balance | 1 |
54 | contemplation/action/maintenance | 2 |
55 | peri-adolescence | 1 |
56 | common-source | 1 |
57 | endpoint-free | 2 |
58 | dual-cartridge | 1 |
59 | year.the | 4 |
60 | nike | 11 |
61 | 1-t-scale | 1 |
62 | nondrainable | 1 |
63 | two-vegetable | 3 |
64 | catheter-over-needle | 6 |
65 | mock-crime | 4 |
66 | four-volume | 2 |
67 | black-line | 2 |
68 | thio-morpholine | 2 |
69 | naphazoline/pheniramine | 2 |
70 | waveone | 30 |
71 | single-stone | 3 |
72 | zero-slope | 1 |
73 | high-use | 8 |
74 | pentalyse | 2 |
75 | pronucleate | 2 |
76 | numb-taste | 1 |
77 | stereoinvertive | 1 |
78 | 15-mg/kg | 13 |
79 | recrudescing | 1 |
80 | milk-feeding | 1 |
81 | sap-feeding | 1 |
82 | 'fishing | 1 |
83 | enneking | 2 |
84 | d-labeling | 1 |
85 | self-cooling | 1 |
86 | stone-bearing | 4 |
87 | heading/flowering | 1 |
88 | mid-heating | 1 |
89 | non-coordinating | 6 |
90 | taste-testing | 2 |
91 | mrcog | 5 |
92 | kopparberg | 4 |
93 | 25-μg | 6 |
94 | sn-rich | 1 |
95 | fill-finish | 1 |
96 | anji | 1 |
97 | post-outbreak | 1 |
98 | 48-pack | 1 |
99 | start-of-second-crack | 1 |
100 | nonmagical | 2 |
101 | sublinical | 1 |
102 | sabbatical | 1 |
103 | cterminal | 3 |
104 | sepal | 4 |
105 | 2-mp-general | 5 |
106 | l2-larval | 1 |
107 | chisel | 11 |
108 | 2-8-cell | 1 |
109 | five-cell | 1 |
110 | four-cell | 6 |
111 | pro-t-cell | 1 |
112 | pre-protocol | 5 |
113 | post-protocol | 11 |
114 | biceps-curl | 2 |
115 | hy-droxy-ethyl | 3 |
116 | 20-cm | 6 |
117 | missing-not-at-random | 2 |
118 | pelican | 7 |
119 | pagan | 2 |
120 | grammian | 2 |
121 | supra-span | 2 |
122 | common-garden | 3 |
123 | common-stress-garden | 1 |
124 | roll-in | 10 |
125 | microthin | 4 |
126 | metformin+pioglitazone+sitagliptin | 1 |
127 | trichiasis/entropion | 1 |
128 | precontemplation-contemplation | 1 |
129 | transconformation | 1 |
130 | relactation | 2 |
131 | change-detection | 2 |
132 | alkali-condition | 1 |
133 | irradiation/absorption | 1 |
134 | step-execution | 2 |
135 | rna-pulldown | 1 |
136 | vasco | 3 |
137 | dep-ado | 7 |
138 | fixed-ratio | 9 |
139 | par4-ap | 2 |
140 | ha/tcp | 5 |
141 | bipronuclear | 3 |
142 | pseudoglandular | 1 |
143 | 10-member | 5 |
144 | calender | 1 |
145 | retract-and-reorder | 2 |
146 | hot-weather | 1 |
147 | middle-later | 1 |
148 | 10-centimeter | 3 |
149 | fall-winter | 1 |
150 | leboyer | 24 |
151 | foscarnet-ganciclovir | 1 |
152 | calbindin-poor | 1 |
153 | mg/cpr | 2 |
154 | 4.6-hour | 1 |
155 | irving-williams | 2 |
156 | accf/aha/hrs | 2 |
157 | valveless | 7 |
158 | pyrophilous | 1 |
159 | anti-blys | 2 |
160 | drug’s | 1 |
161 | 7-product | 3 |
162 | low-fat-diet | 2 |
163 | ten-night | 1 |
164 | temperate-environment | 2 |
165 | kybersept | 2 |
166 | promegakaryoblast | 1 |
167 | noisiest | 2 |
168 | pre-test-feedback-post-test | 1 |
169 | 50-watt | 1 |
170 | center-out | 3 |
171 | non-body | 1 |
172 | no-body | 1 |
173 | 'milky | 1 |
174 | third.only | 1 |
175 | mid-axillary | 7 |
176 | pressure-injury | 1 |
177 | para-meth-oxy | 2 |